Skip to content

Anorexia Nervosa and Brain in Adolescence

Anorexia Nervosa and Brain in Adolescence

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06380257
Enrollment
50
Registered
2024-04-23
Start date
2024-09-30
Completion date
2030-12-31
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorexia Nervosa

Brief summary

Aims of this follow-up study are to investigate effects of anorexia nervosa on brain structure and functions in adolescence.

Detailed description

Anorexia nervosa is severe mental health problem with increased incidence rates in adolescence. Etiology of anorexia nervosa is still mostly unkonwn. Adolescence is also critical period of brain development. Aims of this follow-up study are to investigate effects of anorexia nervosa on brain structure and functions in both acute and remission state of anorexia nervosa in adolescence. Study group are young anorexia nervosa patients, and control group are healthy same-aged students. Research methods include non-invasive brain imaging methods such as Transcranial Magnetic Stimulation (TMS), and Magnetic Resonance Imaging (MRI). Other research methods are assessment of body composition, laboratory tests, self-rated questionnaires and psychiatric interview.

Interventions

OTHERObservational study methods

Neuroimaging, body compostion, laboratory tests and psychiatric interview in study and in control groups.

Sponsors

Kuopio University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to 19 Years
Healthy volunteers
Yes

Inclusion criteria

Study group: 1) age 16-19 years, 2) BMI below 17.5, 3) diagnosis: anorexia nervosa or atypical anorexia nervosa 4) diagnosed within last two years. Inclusion criteria. Control group : 1) age 16-19 years, 2) BMI over 19.0, 3) No lifetime obesity (BMI over 30) nor eating disorder.

Exclusion criteria

1\) glucose metabolism disorder or any chronic medical disorder, or medicine with possible effects on neurotransmitters, 2) previous mental health problem (excluded anorexia nervosa or atypical anorexia nervosa in study group), 3) smoking, nicotine products, alcohol or any other substance abuse or dependence, 4) contraindication for used brain imaging method.

Design outcomes

Primary

MeasureTime frameDescription
NeuroimagingBaseline and at 3 years' follow-upTranscranial magnetic stimulation (TMS) combined with electroencephalogram (EEG)

Secondary

MeasureTime frameDescription
NeuroimagingBaseline and at 3 years' follow-upMagnetic resonance imaging (MRI)

Other

MeasureTime frameDescription
Psychiatric evaluationBaseline and at 3 years' follow-upSelf-rated questionnaires measuring somatic and mentalh health (such as EDE-Q, BDI, substance use measurements) and structured psychiatric diagnostic interview (SCID)
Body composition measurementBaseline and at 3 years' follow-upInBody body composition measurement (non-invasive method to measure information about the quantity and segmentation of muscle, bone and fat tissue in body and about your basal metabolic rate)
Laboratory testsBaseline and at 3 years' follow-upBlood sample (markers describing undernourishment, more precise description before study)

Contacts

Primary ContactVirve Kekkonen, M.D.
virve.kekkonen@pshyvinvointialue.fi+35817173311

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026